Skip to main content
SpringerLink
Log in

Dynamic Vascular Pattern and Quantitative Analysis in Liver Tumors

  • Chapter
  • First Online:
Contrast-Enhanced Ultrasound Imaging of Hepatic Neoplasms

  • 426 Accesses

Abstract

Contrast enhanced ultrasound (CEUS) with dynamic real-time depiction of tumor perfusion and the fact that it is a purely intravascular agent, accurately reflecting tumoral and inflammatory blood flow. When using special external software, dynamic perfusion parameters can be recorded using motion correction. The most common parameters of a dynamic perfusion analysis are time to peak (TTP) and area under the curve (AUC), the mean transit time (mTT), the wash in and wash out rate, and the peak enhancement. With the wash in and wash out kinetics of the CEUS perfusion, different malignant or benign liver tumors can be possible. CEUS Perfusion can also be very helpful in assessing early treatment response to malignant liver lesions. CEUS is gaining ever-increasing acceptance in the preoperative and postoperative evaluation of liver-transplanted patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wilson SR, Burns PN, Kono Y. Contrast-enhanced ultrasound of focal liver masses: a success story. Ultrasound Med Biol. 2020;46:1059–70.

    Article  Google Scholar 

  2. Sidhu PS, Cantisani V, Dietrich CF, Gilja OH, Saftoiu A, Bartels E, Bertolotto M, et al. The EFSUMB guidelines and recommendations for the clinical practice of Contrast-Enhanced Ultrasound (CEUS) in non-hepatic applications: update 2017 (long version). Ultraschall Med. 2018;39:e2–e44.

    Article  Google Scholar 

  3. Beyer LP, Wassermann F, Pregler B, Michalik K, Rennert J, Wiesinger I, Stroszczynski C, et al. Characterization of focal liver lesions using CEUS and MRI with liver-specific contrast media: experience of a single radiologic center. Ultraschall Med. 2017;38:619–25.

    Article  Google Scholar 

  4. Tranquart F, Dujardin PA, Bouche O, Marcus C, Borg C, Manzoni P, Douillard JY, et al. Value of contrast-enhanced ultrasound quantification criteria for identifying patients not responding to bevacizumab-based therapy for colorectal liver metastases. Ultraschall Med. 2018;39:544–58.

    Article  Google Scholar 

  5. Lu Q, Zhang XL, Han H, Huang BJ, Ding H, Wang WP. Value of perfusion parameters for differentiating hepatocellular carcinoma and liver metastasis with hypervascularity and a normal hepatic background on contrast-enhanced ultrasound imaging. J Ultrasound Med. 2019;38:2601–8.

    Article  Google Scholar 

  6. Wildner D, Schellhaas B, Strack D, Goertz RS, Pfeifer L, Fiessler C, Neurath MF, et al. Differentiation of malignant liver tumors by software-based perfusion quantification with dynamic contrast-enhanced ultrasound (DCEUS). Clin Hemorheol Microcirc. 2019;71:39–51.

    Article  Google Scholar 

  7. Denis de Senneville B, Frulio N, Laumonier H, Salut C, Lafitte L, Trillaud H. Liver contrast-enhanced sonography: computer-assisted differentiation between focal nodular hyperplasia and inflammatory hepatocellular adenoma by reference to microbubble transport patterns. Eur Radiol. 2020;30:2995–3003.

    Article  Google Scholar 

  8. Strobel D, Seitz K, Blank W, Schuler A, Dietrich C, von Herbay A, Friedrich-Rust M, et al. Contrast-enhanced ultrasound for the characterization of focal liver lesions–diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall Med. 2008;29:499–505.

    Article  CAS  Google Scholar 

  9. Schellhaas B, Hammon M, Strobel D, Pfeifer L, Kielisch C, Goertz RS, Cavallaro A, et al. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS. Eur Radiol. 2018;28:4254–64.

    Article  Google Scholar 

  10. Schelker RC, Andorfer K, Putz F, Herr W, Jung EM. Identification of two distinct hereditary hemorrhagic telangiectasia patient subsets with different hepatic perfusion properties by combination of contrast-enhanced ultrasound (CEUS) with perfusion imaging quantification. PLoS One. 2019;14:e0215178.

    Article  CAS  Google Scholar 

  11. Kuorda H, Abe T, Fujiwara Y, Okamoto T, Yonezawa M, Sato H, Endo K, et al. Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma. World J Gastroenterol. 2019;25:2365–72.

    Article  Google Scholar 

  12. Rennert J, Wiesinger I, Schicho A, Beyer LP, Wiggermann P, Stroszczynski C, Jung EM. Color coded perfusion imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following trans-arterial chemoembolization (TACE) of hepatocellular carcinoma. PLoS One. 2019;14:e0217599.

    Article  CAS  Google Scholar 

  13. Rennert J, Wiesinger I, Beyer LP, Schicho A, Stroszczynski C, Wiggermann P, Jung EM. Color coded perfusion analysis and microcirculation imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following thermal ablative techniques of primary and secondary liver malignancies. Clin Hemorheol Microcirc. 2019;73:73–83.

    Article  Google Scholar 

  14. Rennert J, Wiesinger I, Schicho A, Wiggermann P, Stroszczynski C, Beyer LP, Jung EM. Color coded perfusion imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following irreversible electroporation (IRE) of primary and secondary malignant liver lesions. J Gastrointestin Liver Dis. 2019;28:311–8.

    Article  Google Scholar 

  15. Zhou G, Cai ZQ, Luo J, Hu ZX, Luo H, Wu H, Chen Q. Prognostic value of enhancement rate by enhanced ultrasound in hepatitis B virus-positive hepatocellular carcinoma undergoing radiofrequency ablation. Asia Pac J Clin Oncol. 2019;15:238–43.

    Article  Google Scholar 

  16. Wiesinger I, Wiggermann P, Zausig N, Beyer LP, Salzberger B, Stroszczynski C, Jung EM. Percutaneous treatment of malignant liver lesions: evaluation of success using contrast-enhanced ultrasound (CEUS) and perfusion software. Ultraschall Med. 2018;39:440–7.

    Article  Google Scholar 

  17. Como G, Montaldo L, Baccarani U, Lorenzin D, Zuiani C, Girometti R. Contrast-enhanced ultrasound applications in liver transplant imaging. Abdom Radiol (NY). 2020;

    Google Scholar 

  18. Yi H, Cai B, Ai X, Liu R, Li K, Zhang W. Value of contrast-enhanced ultrasound for preoperative assessment of liver reserve function in patients with liver tumors. PLoS One. 2019;14:e0222514.

    Article  CAS  Google Scholar 

  19. Yang D, Li R, Zhang XH, Tang CL, Ma KS, Guo DY, Yan XC. Perfusion characteristics of hepatocellular carcinoma at contrast-enhanced ultrasound: influence of the cellular differentiation, the tumor size and the underlying hepatic condition. Sci Rep. 2018;8:4713.

    Article  Google Scholar 

  20. Schaible J, Stroszczynski C, Beyer LP, Jung EM. Quantitative perfusion analysis of hepatocellular carcinoma using dynamic contrast enhanced ultrasound (CEUS) to determine tumor microvascularization. Clin Hemorheol Microcirc. 2019;73:95–104.

    Article  CAS  Google Scholar 

  21. Haimerl M, Poelsterl S, Beyer LP, Wiesinger I, Nießen C, Stroszczynski C, Wiggermann P, et al. Chronic liver disease: quantitative MRI vs CEUS-based microperfusion. Clin Hemorheol Microcirc. 2016;64:435–46.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, University Hospital Regensburg, Regensburg, Germany

    Ernst Michael Jung

  2. Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, China

    Yi Dong

Authors
  1. Ernst Michael Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yi Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ernst Michael Jung .

Editor information

Editors and Affiliations

  1. Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, China

    Wen-Ping Wang

  2. Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, China

    Yi Dong

  3. Allgemeine Innere Medizin, Kliniken Hirslanden Beau Site & Salem und Permanence Bern, Bern, Switzerland

    Christoph F. Dietrich

  4. Institute of Diagnostic Radiology, Interdisciplinary Ultrasound Department, University Hospital Regensburg, Regensburg, Germany

    Ernst Michael Jung

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Jung, E.M., Dong, Y. (2021). Dynamic Vascular Pattern and Quantitative Analysis in Liver Tumors. In: Wang, WP., Dong, Y., Dietrich, C.F., Jung, E.M. (eds) Contrast-Enhanced Ultrasound Imaging of Hepatic Neoplasms. Springer, Singapore. https://doi.org/10.1007/978-981-16-1761-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-981-16-1761-4_12

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-16-1760-7

  • Online ISBN: 978-981-16-1761-4

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics

Search

Navigation